Geron reported $69.12M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Amgen USD 6.58B 146M Jun/2025
Bio Techne USD 189.45M 1.64M Jun/2025
Cytokinetics 0 0 Dec/2023
Exelixis USD 23.48M 1.37M Jun/2025
Genmab DKK 13M 1000K Jun/2025
Geron USD 69.12M 12.9M Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
Incyte USD 83.42M 19.45M Jun/2025
MacroGenics USD 9.28M 9.28M Jun/2025
Novartis USD 6.31B 478M Jun/2025